Comparison of Traditional, Synchronous, and Asynchronous Telerehabilitation in Office Workers With Chronic Nonspecific Low Back Pain

July 13, 2026 updated by: Özge Mine Yilmaz, Istanbul Aydın University

Comparison of the Effectiveness of Traditional, Synchronous, and Asynchronous Telerehabilitation Approaches in Chronic Nonspecific Low Back Pain in Office Workers

Chronic Nonspecific Low Back Pain (NLBP) is a common condition that occurs without a specific underlying pathology, resulting in muscle tension, pain, and a decreased quality of life. Office workers are particularly at risk due to prolonged sitting, ergonomic errors, and low physical activity. While exercise therapy is a primary approach for management, low adherence rates often limit its effectiveness. Telerehabilitation (remote, technology-supported physiotherapy) stands out for its potential to increase access and support continuity of care.

This study is a randomized controlled trial that will be conducted with 45 office workers aged 18-65 diagnosed with chronic NLBP. Participants will be randomly assigned to three parallel groups: traditional exercise (brochure-based), synchronous telerehabilitation (live sessions), and asynchronous telerehabilitation (pre-recorded videos). The intervention protocol will be implemented for 8 weeks. Evaluations will be performed before and after the 8-week period using the Visual Analog Scale (VAS) for pain intensity, Oswestry Disability Index (ODI) for functional disability, Short Form-36 (SF-36) for health-related quality of life, and a Patient Satisfaction Questionnaire.

The aim of this study is to compare the effects of traditional, synchronous, and asynchronous telerehabilitation approaches on pain, disability, quality of life, and satisfaction to determine the most effective management model for office workers with chronic nonspecific low back pain.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
45

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey (Türkiye)
      • Istanbul, Turkey (Türkiye), 34295
        • Istanbul Aydin University, Faculty of Health Sciences
        • Contact:
        • Principal Investigator:
          • Özge Mine YILMAZ, Ass Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being an office worker aged between 18 and 65 years.
  • Diagnosed with chronic non-specific low back pain (symptoms persisting for more than 3 months).
  • Volunteering to participate in the study and signing the informed consent form.
  • Having a computer, smartphone, or tablet with a stable internet connection capable of supporting video calls.

Exclusion Criteria:

  • - History of spinal surgery, structural spinal deformities (e.g., severe scoliosis), or specific causes of low back pain (e.g., disc herniation with severe radiculopathy, spinal stenosis, spondylolisthesis).
  • Diagnosis of systemic, rheumatological, neurological, or inflammatory diseases affecting the musculoskeletal system.
  • Serious cardiovascular or pulmonary conditions that contraindicate physical exercise.
  • Currently receiving active physical therapy or regular medical intervention for low back pain elsewhere.
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Traditional Exercise Group
Participants will receive a standard physiotherapy program including stretching, core stabilization, and motor control exercises for low back pain, delivered face-to-face by a physiotherapist in a clinical environment at Istanbul Aydın University
Behavioral: Face-to-Face Clinic-Based Exercise
The exercise protocol consists of stretching, core stabilization, and motor control exercises for low back pain. Frequency: Performed 3 days a week for 8 weeks, consisting of 2 sets of 10 repetitions (approximately 45-60 minutes per session). It will be delivered face-to-face by a physiotherapist in a clinical environment at Istanbul Aydin University.
Experimental: Synchronous Telerehabilitation Group
Participants will participate in the same exercise program (stretching, core stabilization, and motor control exercises) via live, real-time online video sessions supervised by a physiotherapist.
Behavioral: Synchronous Telerehabilitation Exercise
The exercise protocol consists of stretching, core stabilization, and motor control exercises for low back pain. Frequency: Performed 3 days a week for 8 weeks, consisting of 2 sets of 10 repetitions (approximately 45-60 minutes per session). It will be delivered via live, real-time online video sessions supervised by a physiotherapist.
Experimental: Asynchronous Telerehabilitation Group
Participants will be provided with pre-recorded instructional exercise videos containing the same program. They will follow and perform the exercises individually at their own convenience.
Behavioral: Asynchronous Telerehabilitation Exercise
The exercise protocol consists of stretching, core stabilization, and motor control exercises for low back pain. Frequency: Performed 3 days a week for 8 weeks, consisting of 2 sets of 10 repetitions (approximately 45-60 minutes per session). Participants will be provided with pre-recorded instructional exercise videos and follow the exercises individually at their own convenience.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Functional Disability Level
Time Frame: Baseline and Post-intervention (Week 8)
Evaluated using the Oswestry Disability Index (ODI) to measure functional disability related to low back pain. The questionnaire consists of 10 items, and the total score is expressed as a percentage ranging from 0% to 100%. A score of 0% indicates no disability, while 100% represents the highest possible level of functional disability. Higher percentages mean a worse functional outcome.
Baseline and Post-intervention (Week 8)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Health-Related Quality of Life
Time Frame: Baseline and Post-intervention (Week 8)
Evaluated using the Short Form-36 (SF-36) questionnaire, which measures 8 health domains. Scores range from 0 to 100 for each domain, where higher scores represent a better health-related quality of life.
Baseline and Post-intervention (Week 8)
Pain Intensity Assessed via Visual Analog Scale (VAS)
Time Frame: Baseline and Post-intervention (Week 8)
Measured using the Visual Analog Scale (VAS) for low back pain, where participants rate their pain on a 10-centimeter horizontal line. Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the most severe imaginable pain. Higher scores represent worse pain outcomes.
Baseline and Post-intervention (Week 8)
Patient Satisfaction
Time Frame: Post-intervention (Week 8)
Measured using the Physiotherapy and Rehabilitation Patient Satisfaction Questionnaire. Total scores range from 0 to 100 (converted from the multi-item scale), where 0 indicates total dissatisfaction and 100 indicates the highest level of satisfaction. Higher scores mean a better outcome.
Post-intervention (Week 8)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istanbul Aydın University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
The Scientific and Technological Research Council of Turkey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 6, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 13, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 14, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 14, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 13, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • TUBITAK-1919B012522773

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings